Page 144 - GPD-3-4
P. 144

Gene & Protein in Disease                                      A pyroptosis-related gene signature in myeloma



               doi: 10.1038/s41419-019-1883-8                     defined pyroptosis-related gene signature for the prognosis
                                                                  of bladder cancer. Int J Gen Med. 2021;14:8109-8120.
            20.  Shi M, Tang C, Wu JX,  et al. Mass spectrometry detects
               sphingolipid metabolites for discovery of new strategy for      doi: 10.2147/ijgm.S337735
               cancer therapy from the aspect of programmed cell death.   32.  Du H, Xie S, Guo W, et al. Development and validation of
               Metabolites. 2023;13(7):867.
                                                                  an autophagy-related prognostic signature in esophageal
               doi: 10.3390/metabo13070867                        cancer. Ann Transl Med. 2021;9(4):317.
            21.  Rao Z, Zhu Y, Yang P,  et al. Pyroptosis in inflammatory      doi: 10.21037/atm-20-4541
               diseases and cancer. Theranostics. 2022;12(9):4310-4329.
                                                               33.  Yang Y, Wu G, Li Q,  et al. Angiogenesis-related
               doi: 10.7150/thno.71086                            immune  signatures  correlate  with  prognosis,  tumor
                                                                  microenvironment,  and  therapeutic  sensitivity  in
            22.  He Y, Jiang S, Cui Y, et al. Induction of IFIT1/IFIT3 and   hepatocellular carcinoma. Front Mol Biosci. 2021;8:690206.
               inhibition of Bcl-2 orchestrate the treatment of myeloma
               and leukemia via pyroptosis. Cancer Lett. 2024;588:216797.     doi: 10.3389/fmolb.2021.690206
               doi: 10.1016/j.canlet.2024.216797               34.  Fang Y, Huang S, Han L, Wang S, Xiong B. Comprehensive
                                                                  analysis of peritoneal metastasis sequencing data to identify
            23.  Chen LL, Chen X, Choi H, et al. Exploiting antitumor immunity   LINC00924  as  a  Prognostic  biomarker  in  gastric  cancer.
               to overcome relapse and improve remission duration. Cancer   Cancer Manag Res. 2021;13:5599-5611.
               Immunol Immunother. 2012;61(7):1113-1124.
                                                                  doi: 10.2147/cmar.S318704
               doi: 10.1007/s00262-011-1185-1
                                                               35.  Yuan  M,  Wang  Y,  Sun  Q,  et  al.  Identification  of  a  nine
            24.  Guner  A,  Kim  HI.  Biomarkers  for  evaluating  the   immune-related lncRNA signature as a novel diagnostic
               inflammation status in patients with cancer. J Gastric Cancer.   biomarker  for  hepatocellular  carcinoma.  Biomed Res  Int.
               2019;19(3):254-277.
                                                                  2021;2021:9798231.
               doi: 10.5230/jgc.2019.19.e29
                                                                  doi: 10.1155/2021/9798231
            25.  Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis:
               Mechanisms and diseases.  Signal Transduct Target Ther.   36.  Dai Y, Qiang W, Lin K, Gui Y, Lan X, Wang D. An
               2021;6(1):128.                                     immune-related gene signature for predicting survival
                                                                  and  immunotherapy  efficacy  in  hepatocellular  carcinoma.
               doi: 10.1038/s41392-021-00507-5                    Cancer Immunol Immunother. 2021;70(4):967-979.
            26.  Wang H, Shao R, Lu S,  et al. Integrative analysis of a      doi: 10.1007/s00262-020-02743-0
               pyroptosis-related signature of clinical and biological value
               in multiple myeloma. Front Oncol. 2022;12:845074.  37.  Zhao WJ, Ou GY, Lin WW. Integrative analysis of neuregulin
                                                                  family  members-related tumor microenvironment for
               doi: 10.3389/fonc.2022.845074                      predicting the prognosis in gliomas.  Front Immunol.
            27.  Zhang C, Wu S, Chen B. A novel prognostic model based on   2021;12:682415.
               pyroptosis-related genes for multiple myeloma. BMC Med      doi: 10.3389/fimmu.2021.682415
               Genomics. 2023;16(1):32.
                                                               38.  Fu J, Li K, Zhang W, et al. Large-scale public data reuse to
               doi: 10.1186/s12920-023-01455-5                    model immunotherapy response and resistance.  Genome
            28.  Li C, Liang H, Bian S, Hou X, Ma Y. Construction of a   Med. 2020;12(1):21.
               prognosis model of the pyroptosis-related gene in multiple      doi: 10.1186/s13073-020-0721-z
               myeloma and screening of core genes.  ACS Omega.   39.  Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction
               2022;7(38):34608-34620.
                                                                  and exclusion predict cancer immunotherapy response.
               doi: 10.1021/acsomega.2c04212                      Nature Med. 2018;24(10):1550-1558.
            29.  Yuan C, Yuan M, Chen M, et al. Prognostic implication of      doi: 10.1038/s41591-018-0136-1
               a novel metabolism-related gene signature in hepatocellular   40.  Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce
               carcinoma. Front Oncol. 2021;11:666199.
                                                                  pyroptosis through caspase-3 cleavage of a gasdermin.
               doi: 10.3389/fonc.2021.666199                      Nature. 2017;547(7661):99-103.
            30.  Ye J, She X, Liu Z, et al. Eukaryotic initiation factor 4A-3:      doi: 10.1038/nature22393
               A  review of its physiological role and involvement in   41.  Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-mediated
               oncogenesis. Front Oncol. 2021;11:712045.
                                                                  programmed necrotic cell death.  Trends Biochem Sci.
               doi: 10.3389/fonc.2021.712045                      2017;42(4):245-254.
            31.  Chen  W,  Zhang  W,  Zhou  T,  Cai  J,  Yu  Z,  Wu  Z.  A  newly      doi: 10.1016/j.tibs.2016.10.004


            Volume 3 Issue 4 (2024)                         15                              doi: 10.36922/gpd.4534
   139   140   141   142   143   144   145   146   147   148